Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C

Hepato-Gastroenterology

Volumn 44, Issue 14, 1997, Pages 525-528

  Okano, Jun Ichi ^a   Horie, Yutaka ^a   Kawasaki, Hironaka ^a   Kondo, Masao ^b  

^a TOTTORI UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Ferritin; Hepatitis C virus; Interferon; Porphyria cutanea tarda

Indexed keywords

AMINOTRANSFERASE; BETA INTERFERON; COPROPORPHYRIN; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; UROPORPHYRIN; VIRUS RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; DRUG EFFICACY; FERRITIN BLOOD LEVEL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; URINARY EXCRETION;

ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; COPROPORPHYRINS; FERRITINS; GAMMA-GLUTAMYLTRANSFERASE; HEPACIVIRUS; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; INJECTIONS, INTRAVENOUS; INTERFERON-BETA; MALE; MIDDLE AGED; PORPHYRIA CUTANEA TARDA; RNA, VIRAL; UROPORPHYRINS;

EID: 0030891581     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Kappas A, Sassa S, Galbraith RA, Nordmanh Y. The Porphyrias. In: Scriver CR, Beagudet A, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. New York: Mac Graw-Hill Inc., 1989; 1305-1365.
2. Bissel DM, Schmidt R. Hepatic porphyrias. In: Schiff L, Schiff ER, eds. Diseases of the Liver. Philadelphia, J.B. Lippincott Company 1989; 1025-1088.
3. Kushner JP. Laboratory diagnosis of the porphyrias. N Engl J Med 1991; 324:1432-1434.
4. Fargion S, Piperno A, Cappellmi MD, Sampietro M, Fracanzani AL, Romano R, Caldarelli R, Marcelli R, Vecchi L, Fiorelli G. Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association. Hepatology 1992; 16: 1322-1326.
5. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J, Teres J, Mascaro JM, Rodes J. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993; 341: 788-789.
6. DeCastro M, Sanchez J, Herrera JF, Chaves A, Duran R, Garcia-Buey L, Garcia-Monzon C, Sequi J, Moreno-Otero R. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 1993; 17: 551-557.
7. Ferri G, Baicchi U, Civita LL, Greco F, Longombardo G, Mazzoni A, Careccia G, Bombardieri S, Pasero G, Zignego AL, Manns MP. Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur J Clin Invest 1993; 23: 851-855.
8. Baicchi U, Moretti A, Carrai M, Fosella PV. Prevalence of anti hepatitis C virus antibodies in porphyria cutanea tarda. Conference on recent progress in viral hepatitis. Pisa, May 4, 1990 Ed.Ortho Diagnostic Systems. pp.100-101.
9. Navas S, Bosch O, Castillo I, Marriot E, Carreno V. Porphyria cutanea tarda and hepatitis C and B viruses infection: A retrespective study. Hepatology 1995; 21: 279-284.
10. Dohmen K, Nakamura H, Morita C, Arase K, Yokogawa Y, Asayama R, Ishibashi H. Chronic hepatitis C associated with porphyria cutanea tarda. Jpn J Gastroenterol 1994; 91: 345-349 (in Japanese).
11. Siegel LB, Eber BB. Porphyria cutanea tarda remission. Ann Int Med 1994; 121: 308-309.
12. Gresser I, Tovey MG, Maury C. Lethality of interferon preparations for newborn mice. Nature 1975; 258: 76-78.
13. Bonkovsky HL. Mechanism of iron potentiation of hepatic uroporphyria: studies in cultured chick embryo liver cells. Hepatology 1989; 10: 354-364.